Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy-Reference-Cited by-同舟云学术

Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy

Published:2022-12 Issue: Volume:137 Page:108958
ISSN:1525-5050
Container-title:Epilepsy & Behavior
language:en
Short-container-title:Epilepsy & Behavior

Author:

Villanueva Vicente,García-Ron Adrián,Smeyers Patricia,Arias Eva,Soto Victor,García-Peñas Juan José,González-Alguacil Elena,Sayas Débora,Serrano-Castro Pedro,Garces Mercedes,Hampel Kevin,Tomás Miguel,Lara Julian,de Toledo María,Barceló Ines,Aledo-Serrano Angel,Gil-Nagel Antonio,Iacampo Lucas,Falip Mercè,Saiz-Diaz Rosa Ana,Gómez-Ibañez Asier,Sopelana David,Sanchez-Larsen Alvaro,López-González Francisco Javier

Funder

Jazz Pharmaceuticals

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Neurology (clinical),Neurology

Reference34 articles.

1. ILAE Classification of the Epilepsies position paper of the ILAE Commission for Classification and Terminology;Scheffer;Epilepsia,2017

2. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology;Arzimanoglou;Lancet Neurol,2009

3. Pharmacotherapy for Dravet syndrome;Wallace;Pediatr Drugs,2016

4. Sudden unexpected death in Dravet syndrome: respiratory and other physiological dysfunctions;Kalume;Respir Physiol Neurobiol,2013

5. Treatment of seizures associated with Lennox-Gastaut and Dravet syndromes: a focus on cannabidiol oral solution;Lazaridis;Pharm Ther,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabidiol alleviates suture-induced corneal pathological angiogenesis and inflammation by inducing myeloid-derived suppressor cells;International Immunopharmacology;2024-08

2. A Cost-Utility Analysis of Add-On Cannabidiol Versus Usual Care Alone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex in England and Wales;PharmacoEconomics - Open;2024-03-05

3. Efficacy and tolerability of add‐on stiripentol in real‐world clinical practice: An observational study in Dravet syndrome and non‐Dravet developmental and epileptic encephalopathies;Epilepsia Open;2023-11-08

4. Highly purified cannabidiol in the treatment of drug-resistant epilepsies: A real-life impact on seizure frequency, quality of life, behavior, and sleep patterns from a single Italian center;Epilepsy & Behavior;2023-10

5. Real-World Evidence of Factors Affecting Cannabidiol Exposure in Children with Drug-Resistant Developmental and Epileptic Encephalopathies;Pharmaceutics;2023-08-10